502
Participants
Start Date
October 31, 2016
Primary Completion Date
August 6, 2018
Study Completion Date
August 6, 2018
BIIB074
Administered as specified in the treatment arm
Placebo
Matched placebo
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Blagoevgrad
Research Site, Leuven
Research Site, Sofia
Research Site, Veliko Tarnovo
Research Site, Rousse
Research Site, Klagenfurt
Research Site, Prague
Research Site, Prague
Research Site, Belgrade
Research Site, Prague
Research Site, Prague
Research Site, Granada
Research Site, Milan
Research Site, Belgrade
Research Site, Beroun
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Prachatice
Research Site, Litoměřice
Research Site, Choceň
Research Site, Litomyšl
Research Site, Ostrava
Research Site, Paris
Research Site, Zlín
Research Site, Prague
Research Site, Craiova
Research Site, Cluj-Napoca
Research Site, Tbilisi
Research Site, Tbilisi
Research Site, Tbilisi
Research Site, Tbilisi
Research Site, Rome
Research Site, Liepāja
Research Site, Riga
Research Site, Riga
Research Site, Nieuwegein
Research Site, Bucharest
Research Site, Bucharest
Research Site, Banská Bystrica
Research Site, Dolný Kubín
Reasearch Site, Dubnica nad Váhom
Research Site, Krompachy
Research Site, Pruské
Research Site, Spišská Nová Ves
Research Site, Barcelona
Research Site, Elche
Research Site, Birmingham
Research Site, Edinburgh
Research Site, Liverpool
Research Site, London
Research Site, London
Lead Sponsor
Biogen
INDUSTRY